← Open Payments lookup

LISA GALLUCCI: Open Payments

NPI 1548289986 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,885 in 83 payments from 18 companies in 2025. Trend: 2023 $1,820 · 2024 $1,734 · 2025 $1,885

Food & beverage: $1,885
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.15$324
GENZYME CORPORATION9$279
Janssen Biotech, Inc.7$263
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$231
ABBVIE INC.9$161
Madrigal Pharmaceuticals7$145
Ardelyx, Inc.3$94
Regeneron Healthcare Solutions, Inc.3$66
QOL Medical, LLC2$53
Daiichi Sankyo Inc.2$45

Products named: DUPIXENT, TREMFYA, ENTYVIO, XIFAXAN, REZDIFFRA, IBSRELA, RINVOQ, Sucraid.

Industry payments across MD — which companies pay providers there.